Showing posts with label HEALTH INFORMATION. Show all posts
Showing posts with label HEALTH INFORMATION. Show all posts

Saturday, June 29, 2019

What is a 5-year relative survival rate? Survival Rates for Mesothelioma

What is a 5-year relative survival rate?

relative survival rate compares people with the same type and stage of malignant pleural mesothelioma (MPM) to people in the overall population. For example, if the 5-year relative survival rate for a specific stage of MPM is 30%, it means that people who have that cancer are, on average, about 30% as likely as people who don’t have that cancer to live for at least 5 years after being diagnosed.

Survival Rates for Mesothelioma

Individual Characteristics and Mesothelioma Survival Tumor Location Stage of disease Mesothelioma cell type Age at diagnosis and overall health Gender Race/Ethnicity A 2018 analysis of 888 cases in the National Mesothelioma Virtual Bank cohort identified median overall survival of 15 months, on average, for pleural and peritoneal patients combined. 

The most important factors associated with better survival were age (less then 45), female gender, epithelioid cell type, stage 1 disease, peritoneal occurrence and treatment combining surgery with chemotherapy. Mesothelioma Tumor Location There are four types of mesothelioma, and the site where the cancer originates affects patient outcomes. Survival is significantly better for peritoneal patients. About 40 percent of mesothelioma patients survive at least one year. 

Where do these numbers come from?

The American Cancer Society relies on information from the SEER* database, maintained by the National Cancer Institute (NCI), to provide survival statistics for different types of cancer.
The SEER database tracks 5-year relative survival rates for MPM in the United States, based on how far the cancer has spread. The SEER database, however, does not group cancers by AJCC TNM stages (stage 1, stage 2, stage 3, etc.). Instead, it groups cancers into localized, regional, and distant stages:

Less than 10 percent survive longer than five years. Patients diagnosed in the earliest stage who undergo treatment have a five-year survival rate of 16 percent, according to the American Cancer Society. What Are Mesothelioma Survival Rates? Survival rate typically refers to the percentage of people with cancer who live one and five years after initial diagnosis. These measures are referred to as the one-year and five-year mesothelioma survival rates. When discussing survival rates, you may hear other related terms such as life expectancy, 

which is the average time a person is expected to live based on birth year, current age, gender and other factors. Mesothelioma affects life expectancy because the cancer reduces the number of years a patient is expected to live. 

  • Localized: The cancer is limited to the pleura.
  • Regional: The cancer has spread to nearby structures or to nearby lymph nodes.
  • Distant: The cancer has spread to distant parts of the body such as the liver, bones or pleura on the other side of the body.

5-year relative survival rates for malignant pleural mesothelioma

An advanced peritoneal mesothelioma therapy called hyperthermic intraperitoneal chemotherapy (HIPEC) has significantly improved survival rates for this cancer. The procedure combines cytoreductive surgery and heated chemotherapy. Not everyone qualifies for this aggressive procedure, but more than half who do live at least five years. This compares to a median survival of less than 12 months for patients with pleural tumors. In select studies, heated chemotherapy has boosted peritoneal survival to between 40 and 92 months. A 2015 meta-study published in Translational Oncology analyzed 20 years of data, collected from 1992 to 2012. The five-year survival rate for peritoneal mesothelioma patients was more than five-times higher than the rate for pleural patients.
(Based on people diagnosed with MPM between 2008 and 2014.)
SEER Stage
5-Year Relative Survival Rate
Localized
18%
Regional
11%
Distant
7%
All SEER stages combined
9%

Understanding the numbers

  • These numbers apply only to the stage of the cancer when it is first diagnosed.They do not apply later on if the cancer grows, spreads, or comes back after treatment.
  • These numbers don’t take everything into account. Survival rates are grouped based on how far the cancer has spread, but your age, overall health, how resectable the cancer is, type of mesothelioma, how well the cancer responds to treatment, and other factorscan also affect your outlook.
  • People now being diagnosed with MPM may have a better outlook than these numbers show. Treatments improve over time, and these numbers are based on people who were diagnosed and treated at least five years earlier.


Mesothelioma Survival Rate


Mesothelioma Survival Rate

About 40 percent of mesothelioma patients survive at least one year. Less than 10 percent survive longer than five years. Patients diagnosed in the earliest stage who undergo treatment have a five-year survival rate of 16 percent, according to the American Cancer Society. What Are Mesothelioma Survival Rates? Survival rate typically refers to the percentage of people with cancer who live one and five years after initial diagnosis. These measures are referred to as the one-year and five-year mesothelioma survival rates.
Cancer survival rates are typically measured with 5-year statistics, but mesothelioma statistics often reference 1-year and 3-year statistics as the disease is rarely cured. Survival rates can help patients better understand their prognosis and also help specialists identify potential risk factors driving patient life expectancy. Survival time varies for mesothelioma patients based on type, age, treatment and other factors.

 When discussing survival rates, you may hear other related terms such as life expectancy, which is the average time a person is expected to live based on birth year, current age, gender and other factors. Mesothelioma affects life expectancy because the cancer reduces the number of years a patient is expected to live. 

SurvivalStatistics
Survival rate references a number of people that survived for a certain amount of time after their diagnosis. Survival rate is different from life expectancy in that life expectancyrefers to the average length of time patients with mesothelioma live. Life expectancy is usually referenced in years or months and depends on a variety of factors like staging, mesothelioma location, cell type and patient characteristics. Together, both of these statistics can provide information about an individual’s prognosis.
An advanced peritoneal mesothelioma therapy called hyperthermic intraperitoneal chemotherapy (HIPEC) has significantly improved survival rates for this cancer. The procedure combines cytoreductive surgery and heated chemotherapy. Not everyone qualifies for this aggressive procedure, but more than half who do live at least five years. This compares to a median survival of less than 12 months for patients with pleural tumors. 

Mesothelioma survival rates are impacted by the patient’s age and gender. On average, younger patients have a higher 5-year survival rate than older patients, and women have better overall survival rates than men. This is true for most cancers, as well. Mesothelioma specialists and researchers believe this is due to the overall better health of younger individuals, whereas older patients tend to have other diseases and conditions that could complicate their health and ability to withstand treatment. In relation to gender, more men held asbestos occupations at the height of its use, resulting in higher amounts of long-term exposure.

In select studies, heated chemotherapy has boosted peritoneal survival to between 40 and 92 months. A 2015 meta-study published in Translational Oncology analyzed 20 years of data, collected from 1992 to 2012. The five-year survival rate for peritoneal mesothelioma patients was more than five-times higher than the rate for pleural patients.

What Are Mesothelioma Survival Rates?

What Are Mesothelioma Survival Rates?

Individual Characteristics and Mesothelioma Survival Tumor Location Stage of disease Mesothelioma cell type Age at diagnosis and overall health Gender Race/Ethnicity A 2018 analysis of 888 cases in the National Mesothelioma Virtual Bank cohort identified median overall survival of 15 months, on average, for pleural and peritoneal patients combined.

The most important factors associated with better survival were age (less then 45), female gender, epithelioid cell type, stage 1 disease, peritoneal occurrence and treatment combining surgery with chemotherapy.

 Mesothelioma Tumor Location There are four types of mesothelioma, and the site where the cancer originates affects patient outcomes. Survival is significantly better for peritoneal patients. About 40 percent of mesothelioma patients survive at least one year. Less than 10 percent survive longer than five years.
 Patients diagnosed in the earliest stage who undergo treatment have a five-year survival rate of 16 percent, according to the American Cancer Society.

 What Are Mesothelioma Survival Rates? Survival rate typically refers to the percentage of people with cancer who live one and five years after initial diagnosis. These measures are referred to as the one-year and five-year mesothelioma survival rates. When discussing survival rates, you may hear other related terms such as life expectancy, which is the average time a person is expected to live based on birth year, current age, gender and other factors. Mesothelioma affects life expectancy because the cancer reduces the number of years a patient is expected to live.

An advanced peritoneal mesothelioma therapy called hyperthermic intraperitoneal chemotherapy (HIPEC) has significantly improved survival rates for this cancer. The procedure combines cytoreductive surgery and heated chemotherapy. Not everyone qualifies for this aggressive procedure, but more than half who do live at least five years. This compares to a median survival of less than 12 months for patients with pleural tumors.

In select studies, heated chemotherapy has boosted peritoneal survival to between 40 and 92 months. A 2015 meta-study published in Translational Oncology analyzed 20 years of data, collected from 1992 to 2012. The five-year survival rate for peritoneal mesothelioma patients was more than five-times higher than the rate for pleural patients.

Monday, March 11, 2019

CANCER TREATMENT - URINARY BLADDER CANCER.

CANCER TREATMENT

With Scientifically Proven Results


URINARY BLADDER CANCER

Neck tumors are a type of cancer called squamous cell carcinoma. neck cancers often spread to the lymph nodes of the neck, and this is often the first (and sometimes only) sign of the disease at the time of diagnosis and neck cancer is strongly associated with certain environmental and lifestyle risk factors, including tobacco smoking, alcohol consumption, UV light, particular chemicals used in certain workplaces, and certain strains of viruses, such as human papillomavirus. These cancers are frequently aggressive in their biologic behavior; patients with these types of cancer are at a higher risk of developing another cancer in the neck area. Neck cancer is highly curable if detected early, usually with some form of surgery, but radiation therapy may also play an important role, while chemotherapy is often ineffective. throat cancer usually begins with symptoms that seem harmless enough, like an enlarged lymph node on the outside of the neck, a sore throat or a hoarse sounding voice. However, in the case of throat cancer, these conditions may persist and become chronic. There may be a lump or a sore in the throat or neck that does not heal or go away. There may be difficult or painful swallowing. Speaking may become difficult. There may be a persistent earache (painfull for children and adult). Other possible but less common symptoms include some numbness or paralysis of the face muscles

CANCER TREATMENT - PROSTATE CANCER.

CANCER TREATMENT

With Scientifically Proven Results


PROSTATE CANCER

Prostate cancer, also known as carcinoma of the prostate, is the development of cancer in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, some grow relatively fast. The cancer cells may spread from the prostate to other parts of the body, particularly the bones and lymph nodes. It may initially cause no symptoms. In later stages it can cause difficulty urinating, blood in the urine, or pain in the pelvis, back or when urinating. A disease known as benign prostatic hyperplasia may produce similar symptoms. Other late symptoms may include feeling tired due to low levels of red blood cells.
Factors that increase the risk of prostate cancer include: older age, a family history of the disease, and race. About 99% of cases occur in those over the age of 50. Having a first degree relative with the disease increases the risk 2 to 3 fold. In the United States it is more common in the African American population than the Caucasian population. Other factors that may be involved include a diet high in processed, red meat, or milk products or low in certain vegetables. Prostate cancer is diagnosed by biopsy. Medical imaging may then be done to determine if the cancer has spread to other parts of the body.

CANCER TREATMENT - PANCREAS CANCER.

CANCER TREATMENT

With Scientifically Proven Results


PANCREAS CANCER

Pancreatic cancer arises when there is uncontrolled growth of the cells that make up the pancreas – a glandular organ located behind the stomach. These cancer cells have the ability to invade or spread to other parts of the body.There are a number of different types of pancreatic cancer, but pancreatic adenocarcinoma accounts for about 85% of cases. References to pancreatic cancer often refer only to that type. Adenocarcinomas start within the part of the pancreas that makes digestive enzymes, known as the exocrine pancreas. One to two in every hundred cases are neuroendocrine tumors, and arise from the hormone-producing islet cells in the pancreas. Signs and symptoms of the most common form of pancreatic cancer may include yellow skin, abdominal or back pain, unexplained weight loss, light colored stools, dark urine and loss of appetite. However, there are usually no symptoms in the disease's early stages, and symptoms that are specific enough to suspect pancreatic cancer typically do not start until the disease is already in an advanced stage. By the time of diagnosis the cancer has often spread to other parts of the body.
Pancreatic cancer is rare in those younger than 40, and more than half of cases occur in people over the age of 70. The disease is more common among people who smoke, are obese, have diabetes, or who have certain rare genetic conditions. About 25% of cases are linked to tobacco smoking, while 5–10% are linked to inherited genes. Pancreatic cancer is usually diagnosed by a combination of medical imaging (such as ultrasound and computed tomography), blood tests (such as CEA and CA 19-9) and examination of tissue samples (biopsy). This allows the disease to be divided into stages, from early (stage I) to late (stage IV).Screening the general population has not been found to be effective .

CANCER TREATMENT - NECK CANCER.

CANCER TREATMENT

With Scientifically Proven Results 


NECK CANCER

Neck tumors are a type of cancer called squamous cell carcinoma. neck cancers often spread to the lymph nodes of the neck, and this is often the first (and sometimes only) sign of the disease at the time of diagnosis and neck cancer is strongly associated with certain environmental and lifestyle risk factors, including tobacco smoking, alcohol consumption, UV light, particular chemicals used in certain workplaces, and certain strains of viruses, such as human papillomavirus. These cancers are frequently aggressive in their biologic behavior; patients with these types of cancer are at a higher risk of developing another cancer in the neck area. Neck cancer is highly curable if detected early, usually with some form of surgery, but radiation therapy may also play an important role, while chemotherapy is often ineffective. throat cancer usually begins with symptoms that seem harmless enough, like an enlarged lymph node on the outside of the neck, a sore throat or a hoarse sounding voice. However, in the case of throat cancer, these conditions may persist and become chronic. There may be a lump or a sore in the throat or neck that does not heal or go away. There may be difficult or painful swallowing. Speaking may become difficult. There may be a persistent earache (painfull for children and adult). Other possible but less common symptoms include some numbness or paralysis of the face muscles

CANCER TREATMENT - MOUTH CANCER

CANCER TREATMENT

With Scientifically Proven Results


MOUTH CANCER

Mouth cancer is any cancerous tissue growth located in the oral cavity It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring anatomic structure, such as the nasal cavity. Alternatively, the oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types: teratoma, adenocarcinoma derived from a major or minor salivary gland, lymphoma from tonsillar or other lymphoid tissue, or melanoma from the pigment-producing cells of the oral mucosa. There are several types of oral cancers, but around 90% are squamous cell carcinomas, originating in the tissues that line the mouth and lips. Oral or mouth cancer most commonly involves the tongue. It may also occur on the floor of the mouth, cheek lining, gingiva (gums), lips, or palate (roof of the mouth). Most oral cancers look very similar under the microscope and are called squamous cell carcinoma, but less commonly other types of oral cancer occur, such as Kaposi's sarcoma.[tumor caused by infection with human herpesvirus 8 (HHV8)

CANCER TREATMENT - LUNG CANCER.

CANCER TREATMENT

With Scientifically Proven Results


LUNG CANCER

Lung cancer, also known as carcinoma of the lung or pulmonary carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Lung cancer are due to long-term exposure to tobacco smoke About 10–15% of cases occur in people, who have never smoked. These cases are often caused by a combination of genetic factors and exposure toradon gas, asbestos, or other forms of air pollution, including second-hand smoke.
For management of cancer patients especially Asian countries largely embraced with allopathic medicine. Depending upon the stages of cancer, treatment modalities most commonly used (radiotherapy, surgery and chemotherapy). However, disadvantage of these therapies causes permanent or temporary adverse effects such as loss of hair, loss of appetite, nerve damage, vomiting and nausea etc. An integrated approach is needed to manage cancer using the growing body of knowleged gained through scientific development. Thousands of herbal and traditional compounds are being screened worldwide to validate their use as anti-cancerous drugs.
The science of Ayurveda is supposed to add step on the curative aspects of cancers that have resemblance with clinical entities of arbuda and granthi mentioned in Sushutra samhita. Herbomineral preparation is branch of Ayurveda that deals with medicinal properties of herbometallic and herbomineral compounds known as Rasa shastra and the drugs which are used are known as Rasa Aushadhi. Herbomineral drugs converts the toxic mega particles of metal into safe and efficacious nanoparticles and even smaller picoparticles which explains the usefulness of herbomineral drugs as effective medicines for cancer as prophylactic, palliative, curative, and supportive medicaments. Therefore, Rasayana therapy and its role in cancer management are being screened in almost all leading Ayurveda research institutes in this country. Various constituents of Herbomineral compounds such as gold, silver, lead, iron, and arsenic are never used in the raw form as their raw form causes poisonous and toxic effects LAS02 is polyherbal and herbomineral drug which consisted of purified metal and potent Ayurvedic herbs. The drug is most effective, non toxic and has free radical scavenging properties. So the purpose of this study was to to evaluate the efficacy of LAS02 drug in Lung cancer patients

CANCER TREATMENT - LIVER CANCER.

CANCER TREATMENT

With Scientifically Proven Results

LIVER CANCER

Liver cancer or hepatic cancer (from the Greek hēpar, meaning liver) is a cancer that originates in the liver. Liver tumors are discovered on medical imaging equipment (often by accident) or present themselves symptomatically as an abdominal mass, abdominal pain, yellow skin, nausea or liver dysfunction.
Cause of liver cancer is viral infection with hepatitis B virus or hepatitis C virus. The cancer usually forms secondary to cirrhosis caused by these viruses. For this reason, the highest rates of liver cancer occur where these viruses are endemic, including East-Asia and sub-Saharan Africa. Liver cancers should not be confused with liver metastases, also known as secondary liver cancer, which are cancers that originate from organs elsewhere in the body and migrate to the liver. They are formed from either the liver itself or from structures within the liver, including blood vessels or the bile duct.

CANCER TREATMENT - BLADDER CANCER.

CANCER TREATMENT

With Scientifically Proven Results


GALL BLADDER CANCER

Gallbladder cancer is a relatively uncommon cancer. It has peculiar geographical distribution being common in central and South America, central and eastern Europe, Japan and northern India; it is also common in certain ethnic groups e.g. Native American Indians and Hispanics. If it is diagnosed early enough, it can be cured by removing the gallbladder, part of the liver and associated lymph nodes. Most often it is found after symptoms such as abdominal pain, jaundice and vomiting occur, and it has spread to other organs such as the liver. The incidence of gall bladder cancer is increasing in China as well as north central India. It is a rare cancer that is thought to be related to gallstones building up, which also can lead to calcification of the gallbladder, a condition known as porcelain gallbladder. Porcelain gallbladder is also rare. Some studies indicate that people with porcelain gallbladder have a high risk of developing gallbladder cancer, but other studies question this. The outlook is poor for recovery if the cancer is found after symptoms have started to occur, with a 5-year survival rate close to 3%.

CANCER TREATMENT - ESOPHAGUS CANCER.

CANCER TREATMENT

With Scientifically Proven Results


ESOPHAGUS CANCER

Cancer of the oesophagus, also known as oesophageal cancer, is an uncommon but serious type of cancer that affects the oesophagus (gullet). The oesophagus is the medical name for the gullet, which is part of the digestive system. The oesophagus is the long tube that carries food from the throat to the stomach. The top part of the oesophagus lies behind the windpipe (trachea). The bottom part runs down through the chest between the spine and the heart. Signs and symptoms of hepatitis B, ranging from mild to severe, usually appear about one to four months after you've been infected. Signs and symptoms of hepatitis B may include:
  • Difficulties swallowing (dysphagia)
  • Weight loss
  • Throat pain
  • Persistent cough

CANCER TREATMENT - COLON CANCER.

CANCER TREATMENT

With Scientifically Proven Results


COLON CANCER

Colorectal cancer (also known as colon cancer, rectal cancer or bowel cancer) is the development of cancer in the colon or rectum (parts of the large intestine). It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time.
Most colorectal cancers are due to lifestyle factors and increasing age, with only a small number of cases due to underlying genetic disorders. factors include diet, obesity, smoking, and not enough physical activity. Dietary factors that increase the risk include red and processed meat, as well as alcohol. risk factor is inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis. Some of the inherited conditions that can cause colorectal cancer include: familial adenomatous polyposis and hereditary non-polyposis colon cancer; however, these represent less than 5% of cases. It typically starts as a benign tumor which over time becomes cancerous

CANCER TREATMENT - CERVIX CANCER.

CANCER TREATMENT

With Scientifically Proven Results


CERVIX CANCER

The early stages of cervical cancer may be completely free of symptoms. Vaginal bleeding, contact bleeding, or (rarely) a vaginal mass may indicate the presence of malignancy. Also, moderate pain during sexual intercourse and vaginal discharge are symptoms of cervical cancer. In advanced disease, metastases may be present in the abdomen, lungs or elsewhere.
Symptoms of advanced cervical cancer may include: loss of appetite, weight loss, fatigue, pelvic pain, back pain, leg pain, swollen legs, heavy bleeding from the vagina, bone fractures, and/or (rarely) leakage of urine or feces from the vagina.
  • Total 69 female cervix patients with meam age (30-65 years) are cured.
  • Some hematological and biochemical along with cancer marker CA 125 and tumor size are analyzed in cervix patients.
  • Our treatment with Ayurvedic medicine in these patients, the Hemoglobin are increased and decreased biochemical examination SGOT, SGPT, alkaline phosphatase and lacatate dehydrogenase enzyme activity.
  • CA biomarker is significant decreased in these patients after treatment with our Ayurvedic medicine in comparison to before treatment in these patient.
  • The Erythrocyte Sedmentaion Rate (ESR ) level are reduced in all cervix patients after treatment with our Ayurvedic medicine.
  • Tumor size which are responsible for growth of ovary cancer or cervix are significant decreased in comparison to before treatment in our hospital.
  • Enhance the endogenous antioxidant enzymes in the serum after treatment with our Ayurvedic medicine in these patients.
Based on our scientifically proven results, we can say that we completely cure ovary or cervix cancerthrough the treatment with Ayurvedic medicine.

CANCER TREATMENT - BREATH CANCER.

CANCER TREATMENT

With Scientifically Proven Results


BREAST CANCER

Breast Cancer is a cancer of the glandular breast tissue. Worldwide, breast cancer is the fifth most common cause of cancer death (after lung cancer, stomach cancer, liver cancer and colon cancer). In year 2005, breast cancer caused 502,000 death worldwide. Among worldwide, breast cancer is most common cancer and most common cause of cancer death (1). The known risk factors for breast cancer include family history, Li-Fraumeni syndrome, atypical hyperplasia of the breast, late-age at first full-term pregnancy, early menarche, and late menopause . Because some of these risk factors are not easily modifiable (e.g., genetic predisposition), other strategies for reduction of breast cancer risk must be considered.
For management of cancer patients especially Asian countries largely embraced with allopathic medicine. Depending upon the stages of cancer, treatment modalities most commonly used (radiotherapy, surgery and chemotherapy). However, disadvantage of these therapies causes permanent or temporary adverse effects such as loss of hair, loss of appetite, nerve damage, vomiting and nausea etc.
An integrated approach is needed to manage cancer using the growing body of knowleged gained through scientific development. Thousands of herbal and traditional compounds are being screened worldwide to validate their use as anti-cancerous drugs. The science of Ayurveda is supposed to add step on the curative aspects of cancers that have resemblance with clinical entities of Arbuda and granthi mentioned in Sushutra samhita. Herbomineral preparation is branch of Ayurveda that deals with medicinal properties of herbometallic and herbomineral compounds known as Rasa shastra and the drugs which are used are known as Rasa Aushadhi. Herbomineral drugs converts the toxic mega particles of metal into safe and efficacious nanoparticles and even smaller picoparticles which explains the usefulness of herbomineral drugs as effective medicines for cancer as prophylactic, palliative, curative, and supportive medicaments. Therefore, Rasayana therapy and its role in cancer management are being screened in almost all leading Ayurveda research institutes in this country. Various constituents of Herbomineral compounds such as gold, silver, lead, iron, and arsenic are never used in the raw form as their raw form causes poisonous and toxic effects LAS 02 is polyherbal and herbomineral drug which consisted of purified metal and potent Ayurvedic herbs. The drug is most effective, non toxic and has free radical scavenging properties. So the purpose of this study was to to evaluate the efficacy of LAS02 drug in breast cancer patients.

CANCER TREATMENT - BRAIN CANCER

CANCER TREATMENT

With Scientifically Proven Results


BRAIN CANCER

A brain tumor or intracranial neoplasm occurs when abnormal cells form within the brain. There are two main types of tumors: malignant or cancerous tumors and benign tumors. Cancerous tumors can be divided into primary tumors that started within the brain and those that spread from somewhere else known as brain metastasis tumors; this article deals mainly with primary tumors. All types of brain tumors may produce symptoms that vary depending on the part of the brain involved. These may include headaches, seizures, problem with vision, vomiting, and mental changes. The headache is classically worst in the morning and goes away with vomiting. More specific problems may include difficulty in walking, speaking and with sensation. As the disease progresses unconsciousness may occur.
. The most common types of primary tumors in adults are meningiomas and astrocytomas such as glioblastomas. In children the most common type is medulloblastomas. Diagnosis is usually by medical examination along with computed tomography ormagnetic resonance imaging. This is then often confirmed by biopsy. Based on the finding the tumors are divided into different grades or severity.

Popular Posts

Featured Post

411 teachers in the state unforeseen absent

Salute welcome to my blog today, I have been taken to today, because of the one who is the only one who suffers from the state of the state...